Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women

References

• WHO Scientific Group. Research on the Menopause in the 1990s. WHO Technical Report Series;866. Geneva, Switzerland: World Health Organization, 1999:1–3
   Google Scholar
• Menopause Terminology. International Menopause Society. http://www.imsociety.org/menopause_terminology.php. Last access: January 7th 2012
   Google Scholar
• National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation, 2010:1–3
   Google Scholar
• Azagra R, Roca G, Encabo G, et al. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: Validation of the WHO FRAX™ tool in Spain. BMC Musculoskelet Disord 2011;12:30
   PubMedGoogle Scholar
• Palacios S, Borrego RS, Forteza A. The importance of preventive health care in post-menopausal women. Maturitas 2005;52(Suppl 1):S53–60
   Google Scholar
• Ferrer J, Neyro JL, Estevez A. Identification of risk factors for prevention and early diagnosis of asymptomatic post-menopausal women. Maturitas 2005;52(Suppl 1):S7–22
   Google Scholar
• Nayak S, Roberts MS, Greenspan SL. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med 2011;155:751–61
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Bone Miner Res 1994;9:1137–41
   PubMed Web of Science ®Google Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Technical Report Series;843. Geneva, Switzerland: World Health Organization, 1994:5
   Google Scholar
• Fayers PM, Machin D. Quality of Life: The Assessment, Analysis and Interpretation of Patient-reported Outcomes, 2nd edn. Chichester, UK: John Wiley and Sons, Ltd, 2007:1–10
   Google Scholar
• WHO Scientific Group. Prevention and Management of Osteoporosis. WHO Technical Report Series; 921. Geneva, Switzerland: World Health Organization, 2003:2–5
   Google Scholar
• Aranha LL, Mirón Canelo JA, Alonso Sardón M, Del Pino Montes J, Sáenz González MC. Health-related quality of life in Spanish women with osteoporosis. Rev Saude Publica 2006;40: 298–303
   PubMed Web of Science ®Google Scholar
• Sanfélix-Genovés J, Hurtado I, Sanfélix-Gimeno G, Reig-Molla B, Peiró S. Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study). Health Qual Life Outcomes 2011;9:20
   PubMedGoogle Scholar
• Palacios S, Neyro JL, Puertas JC, Fernández de Cabo S. Clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular disease. Menopause 2013;20:852–9
   PubMed Web of Science ®Google Scholar
• Sans S, Fitzgerald AP, Royo D, Conroy R, Graham I. Calibrating the SCORE cardiovascular risk chart for use in Spain. Rev Esp Cardiol 2007;60:476–85
   PubMed Web of Science ®Google Scholar
• Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001; 93:358–66
   PubMed Web of Science ®Google Scholar
• Palacios S, Ferrer-Barriendos J, Parrilla JJ, et al. Health-related quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale. Med Clin (Barc) 2004;122:205–11
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI: Quality Metric Incorporated, 2002
   Google Scholar
• Vilagut G, Ferrer M, Rajmil L, et al. El Cuestionario de Salud SF-36 español: Una década de experiencia y nuevos desarrollos. Gac Sanit 2005;19:135–50
   PubMedGoogle Scholar
• Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos Int 2005;16:447–55
   PubMed Web of Science ®Google Scholar
• Cortet B, Blotman F, Debiais F, et al. Management of osteoporosis and associated quality of life in post-menopausal women. BMC Musculoskelet Disord 2011;12:7
   PubMedGoogle Scholar
• Hooven FH, Adachi JD, Adami S, et al. The Global Longitudinal Study of Osteoporosis in Women (GLOW):rationale and study design. Osteoporos Int 2009;20:1107–16
   PubMed Web of Science ®Google Scholar
• Adachi JD, Adami S, Gehlbach S, et al.; GLOW Investigators. Impact of prevalent fractures on quality of life: baseline results from the Global Longitudinal Study of Osteoporosis in Women. Mayo Clin Proc 2010;85:806–13
   PubMed Web of Science ®Google Scholar
• Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int 2005;16:861–70
   PubMed Web of Science ®Google Scholar
• Romagnoli E, Carnevale V, Nofroni I, et al. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporos Int 2004;15:975–80
   PubMed Web of Science ®Google Scholar
• Sambrook PN, Silverman SL, Cauley JA, et al. Health- related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone 2011;48: 1298–304
   PubMed Web of Science ®Google Scholar
• Cooper C, Jakob F, Chinn C, et al. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int 2008;19:493–501
   PubMed Web of Science ®Google Scholar
• den Uyl D, Nurmohamed MT, van Tuyl LH, Raterman HG, Lems WF. (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther 2011;13:R5
   PubMed Web of Science ®Google Scholar
• Hadji P, Gottschalk M, Ziller V, Kalder M, Jackisch C, Wagner U. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT). Maturitas 2007;56:312–21
   PubMed Web of Science ®Google Scholar
• de Oliveira Ferreira N, Arthuso M, da Silva R, Pedro AO, Neto AM, Costa-Paiva L. Quality of life in women with postmenopausal osteoporosis: correlation between QUALEFFO 41 and SF-36. Maturitas 2009;62:85–90
   PubMed Web of Science ®Google Scholar